PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
This report contains market size and forecasts of PD-L1 Biomarker Testing Platform in Global, including the following market information:
Global PD-L1 Biomarker Testing Platform Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PD-L1 Biomarker Testing Platform market was valued at 1513.1 million in 2021 and is projected to reach US$ 13220 million by 2028, at a CAGR of 36.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD-L1(22C3) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PD-L1 Biomarker Testing Platform include Agilent Technologies and Roche etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-L1 Biomarker Testing Platform companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-L1 Biomarker Testing Platform Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PD-L1 Biomarker Testing Platform Market Segment Percentages, by Type, 2021 (%)
PD-L1(22C3)
PD-L1(28-8)
PD-L1(SP142)
PD-L1(SP263)
Other
Global PD-L1 Biomarker Testing Platform Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PD-L1 Biomarker Testing Platform Market Segment Percentages, by Application, 2021 (%)
Hospital
Diagnostic Center
Other
Global PD-L1 Biomarker Testing Platform Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PD-L1 Biomarker Testing Platform Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PD-L1 Biomarker Testing Platform revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PD-L1 Biomarker Testing Platform revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies
Roche